Toluene is well metabolized, but a portion is exhaled unchanged. Hepatic P450s catalyze metabolism of toluene primarily to benzyl alcohol and lesser amounts of cresols. Benzyl alcohol is converted by ADH and aldehyde dehydrogenase (ALDH) to benzoic acid, which is primarily conjugated with glycine and eliminated in the urine as hippuric acid.
Toluene is metabolized to benzoic acid, followed by hepatic cytochrome P-450 catalyzed glycine conjugation to form hippuric acid. Approximately 75% to 80% of the absorbed toluene is metabolized to benzoic acid, and 62% to 72% is eliminated by humans in the urine as hippuric acid. As the amount of absorbed toluene is increased, the relative importance of the glucuronide conjugated increased. Relatively small amounts appear in urine as the o-cresol (0.12%-0.43%) and p-cresol where they occur as glucuronide and sulfate derivatives. Less than 2% of the absorbed toluene is eliminated in feces.
In mammalian species, acidic metabolites are conjugated with glycine to form hippuric acid and phenylacetic acid. In humans, the phenylacetic acid metabolite is also conjugated with glutamine to form phenacetylglutamine.
来源:Hazardous Substances Data Bank (HSDB)
代谢
甲苯已知的人类代谢物包括对甲基酚、邻甲酚和苯甲醇。
Toluene has known human metabolites that include 4-Methylphenol, o-Cresol, and Benzyl alcohol.
IDENTIFICATION AND USE: Toluene is a colorless liquid. It is not registered for current pesticide use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses. Toluene is a component of gasoline, paints, inks, lacquers, paint thinners, adhesives, fingernail polish, cleaning agents, and rubber. BTX (a mixture of benzene, toluene, and xylene) is added to gasoline to improve octane ratings. Toluene is used to produce benzene, trinitrotoluene (TNT), nylon, plastics, and polyurethanes. It is also used in production of drugs of abuse. Toluene is a favorite of solvent abusers, who intentionally inhale high concentrations to achieve a euphoric effect. HUMAN EXPOSURE AND TOXICITY: Eye and upper airway irritation occurred after a 6.5 hr exposure to an air level of 100 ppm (377 mg/cu m) toluene, and lacrymation was seen at 500 mg/cu m. Volunteers exposed to 100 ppm (377 mg/cu m) toluene for 6 hr/day for four days suffered from subjective complaints of headache, dizziness and a sensation of intoxication. In subjects exposed to 750 mg/cu m for 8 hr, fatigue, muscular weakness, confusion, impaired coordination, enlarged pupils and accommodation disturbances were experienced; at about 3000 mg/cu m, severe fatigue, pronounced nausea, mental confusion, considerable incoordination with staggering gait and strongly affected pupillary light reflexes were observed. After exposure at the high level, muscular fatigue, nervousness and insomnia lasted for several days. Heavy accidental exposure leads to coma. Studies of women exposed to toluene have shown menstrual disturbances, principally associated with abnormal bleeding. n a case study of two adult white males who suffered from toluene intoxication cardiac arrhythmias were noted. Response seemed to be highly variable among individuals. One person exposed for 2 hr to less than 1890 ppm toluene exhibited a rapid heartbeat (sinus tachycardia), while the second person, exposed for 3 hr, exhibited a slow heartbeat (bradycardia). Severe renal tubular acidosis was observed in five pregnant women who were chronic abusers of paints containing toluene. A 27-year-old male developed cerebral and cerebellar atrophy over a period of five years of extensive glue sniffing. He also developed bilateral optic atrophy with blindness and severe sensorineural hearing loss. CYP2E1 is a versatile phase I drug-metabolizing enzyme responsible for the biotransformation of most volatile organic compounds, including toluene. Human toluene exposure increases CYP2E1 mRNA and modifies its activity in leucocytes. A study of Finnish individuals monitored in an occupational database during the years 1978 to 1983 showed that there was no increase in cancer risk with individuals exposed to toluene with average blood levels of 0.18 mg/L. Chromosome studies on peripheral blood lymphocytes of 34 rotogravure workers in Italy showed no changes when compared with the control group. Several case series have demonstrated that high exposure to toluene through sniffing during pregnancy induces a syndrome that closely resembles the fetal alcohol syndrome, with pre- and postnatal growth deficiency, microcephaly and developmental delay, typical craniofacial features including micrognathia, small palpebral fissures, and ear anomalies. ANIMAL STUDIES: Rats were studied to assess the effects of acute binge-like toluene inhalations (15 or 30 min; ~5,000 ppm) on tasks that examine locomotion, exploration, balance, gait, and neurological functioning for adolescent (1 month), young adult (2-3 months), adult (5-6 months), and older adult (10-12 months) rats. Both motor and neurological functions were impaired following acute toluene inhalation at all ages. However, only the duration to recover from deficits in motor functions differed among age groups, with adolescent and young adult rats requiring notably longer recovery times than older rats. When 0.25, 0.5, or 2.0 mL toluene were applied to 0.7% of the total body surface of guinea pigs, none of the animals died, but reduced body-weight gain occurred. Inhalation of 1400 to 2000 ppm toluene by male rats, 8 hours/day for as little as 3 days resulted in reversible, high-frequency hearing loss. Subcutaneous injection of 50 and 500 mg/kg once a day for 10 days caused decreased sperm counts and serum testosterone in male rats. Rats were dosed with 1.3 g/kg toluene subcutaneously during either week 2 (8-15 days) or week 3 (14-20 days) of pregnancy and evaluated for malformations, development of the skeleton, prenatal growth of the brain and liver, postnatal growth, and behavioral effects. The only toluene-induced change was low birth weight and was found in the rats dosed in the third week of pregnancy. Rabbits exposed 24 hours/day at 1000 mg/cu m (265 ppm) from day 6 to 15 of pregnancy showed increased spontaneous abortions. Mice exposed 24 hours/day at 1000 mg/cu m (265 ppm) on days 6 to 15 of pregnancy and rats exposed to 2400 mg/cu m (636 ppm) on days 7 to 15 of pregnancy showed growth and skeletal retardation. Mice exposed 24 hours/day at 133 ppm toluene on days 6 to 13 of pregnancy and rats exposed 24 hours/day at 399 ppm on days 1 to 8 of pregnancy and on days 9 to 14 of pregnancy showed fetal growth retardation and an increase in skeletal anomalies. There was maternal mortality in these groups. Mice exposed 6 hours/day at 100 ppm toluene during days 1 to 17 of pregnancy showed no significant differences in number of implantation sites, number of fetuses, or mean fetal body weight when compared with control. When toluene was applied to shaved interscapular skin of male mice 3 times per week for 4 weeks, followed by a secondary treatment of 3 times per week for up to 112 weeks, no tumors were observed. Groups of 60 male and female mice that were exposed 6.5 hours/day, 5 days/week for 2 years via inhalation at inhaled 0, 120, 600, or 1200 ppm toluene showed no biologically relevant increases for any non-neoplastic or neoplastic tissue changes. When groups of 60 rats of each sex were exposed via inhalation 6.5 hours/day, 5 days/week for 2 years to atmospheres containing 0, 600, or 1200 ppm toluene, nephropathy occurred in nearly all of the rats. The olfactory and respiratory epithelia showed signs of degeneration with nasal inflammation and metaplasia of the olfactory epithelium (principally in the females). No treatment-related neoplasms occurred in the male rats. and the few scattered tumors found in the females were considered not associated with toluene inhalation. Toluene did not induce gene mutations in Salmonella typhimiurium strain TA98, TA100, TA1535, or TA1537 with or without exogenous metabolic activation. In the mouse lymphoma assay, toluene gave an equivocal response with and without exogenous metabolic activation. Toluene did not induce sister chromatid exchanges or chromosomal aberrations in Chinese hamster ovary cells in the presence or absence of exogenous metabolic activation. ECOTOXICITY STUDIES: The toluene contamination significantly reduced the mass of the cell wall material in the alfalfa roots. Furthermore, the toluene pollution can change the alfalfa root cell wall properties by reducing the cell wall functional groups. These functional groups are probably related to the proteins and polysaccharides in the cell wall.
Toluene is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.
Evaluation: There is inadequate evidence for the carcinogenicity of toluene in humans. There is evidence suggesting lack of carcinogenicity of toluene in experimental animals. Overall evaluation: Toluene is not classifiable as to its carcinogenicity to humans (Group 3).
Under the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005), there is inadequate information to assess the carcinogenic potential of toluene because studies of humans chronically exposed to toluene are inconclusive, toluene was not carcinogenic in adequate inhalation cancer bioassays of rats and mice exposed for life, and increased incidences of mammary cancer and leukemia were reported in a lifetime rat oral bioassay at a dose level of 500 mg/kg-day but not at 800 mg/kg-day.
In a group of 37 rotogravure printers a close correlation (rs = 0.78) was found between the time weighted toluene exposure during a five day working week (range 8-416 mg/cu m, median 75) and the concentration of toluene in subcutaneous adipose tissue (range 1.1-20.7 mg/kg, median 3.8). After exposure ceased, the elimination of toluene was followed up in 11 subjects. The toluene concentration in venous blood decreased non-linearly and the elimination curves contained at least three exponential components. The first two had median estimated half times of nine minutes and two hours respectively. The third component, with a median half time of 90 hours, reflected the decline in adipose tissue, which had a median half time of 79 hours (range 44-178). The study showed protracted endogenous toluene exposure from adipose tissue depots long after the end of exogenous exposure. The observations also suggest that the blood toluene concentrations on Monday mornings might be used as an index of the exposure in the previous week.
Studies quantifying oral absorption of toluene are limited but have demonstrated nearly 100% absorption following a single oral exposure. In volunteers exposed to an infusion of 2 mg toluene/minute for 3 hours (~5 mg/kg) via a gastric tube, absorption of toluene, measured by monitoring exhaled air for toluene and urine for toluene metabolites, was found to be complete. /Another study/ reported that greater than 99% of a single gavage dose of radiolabeled toluene in rats was eliminated in the urine or expired air, indicating near-total absorption of the exposure dose.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
甲苯通过人体皮肤吸收速度较慢,吸收率范围在14到23毫克/平方厘米-小时。
Toluene is absorbed through human skin slowly, with absorption rates ranging from 14 to 23 mg/sq cm-hour.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
在人和动物的研究中已经表明,体内的大部分甲苯通过尿液排出,主要是以代谢物的形式。
Studies in both humans and animals have shown that the majority of toluene in the body is eliminated in the urine, mainly as metabolites.
Iron-catalyzed thioesterification of methylarenes with thiols in water
作者:Liang Wang、Jing Cao、Qun Chen、Ming-yang He
DOI:10.1016/j.tetlet.2014.10.155
日期:2014.12
An iron-catalyzed coupling reaction of methylarenes with thiols leading to thioesters has been developed. The reactions were carried out in water with tert-butyl hydroperoxide (TBHP) as the oxidant and polyoxyethanyl α-tocopheryl sebacate (PTS) as the surfactant. The reaction medium is compatible with a series of functional groups and can be reused.
Facile Approach for C(sp3)–H Bond Thioetherification of Isochroman
作者:Chun Cai、Jie Feng、Guoping Lu、Meifang Lv
DOI:10.1055/s-0034-1380125
日期:——
An unprecedented C–S formation protocol via the direct oxidative C(sp3 )–H bond thioesterification of isochroman under metal-free conditions was developed. A series of isochroman derivatives could be afforded efficiently by the green, simple, and atom-economical method.
Copper-Catalyzed Protodecarboxylation of Aromatic Carboxylic Acids
作者:Lukas J. Gooßen、Werner R. Thiel、Nuria Rodríguez、Christophe Linder、Bettina Melzer
DOI:10.1002/adsc.200700223
日期:2007.10.8
A catalyst generated from copper(I) oxide and 4,7-diphenyl-1,10-phenanthroline for the first time allows the catalytic protodecarboxylation even of deactivated aromatic carboxylic acids, giving rise to the corresponding arenes. Based on DFT calculations, a reaction pathway is proposed that accurately reflects the experimental results, such as the observed reactivity order of the substrates.
Metal-Free Intermolecular Oxidative C–N Bond Formation via Tandem C–H and N–H Bond Functionalization
作者:Abhishek A. Kantak、Shathaverdhan Potavathri、Rose A. Barham、Kaitlyn M. Romano、Brenton DeBoef
DOI:10.1021/ja2087085
日期:2011.12.14
development of a novel intermolecular oxidative amination reaction, a synthetic transformation that involves the simultaneous functionalization of both a N-H and C-H bond, is described. The process, which is mediated by an I(III) oxidant and contains no metal catalysts, provides a rapid and green method for synthesizing protected anilines from simple arenes and phthalimide. Mechanistic investigations
Homogeneous Catalytic Hydrogenation of Amides to Amines
作者:Jacorien Coetzee、Deborah L. Dodds、Jürgen Klankermayer、Sandra Brosinski、Walter Leitner、Alexandra M. Z. Slawin、David J. Cole-Hamilton
DOI:10.1002/chem.201204270
日期:2013.8.12
Hydrogenation of amides in the presence of [Ru(acac)3] (acacH=2,4‐pentanedione), triphos [1,1,1‐tris‐ (diphenylphosphinomethyl)ethane] and methanesulfonic acid (MSA) produces secondary and tertiary amines with selectivities as high as 93 % provided that there is at least one aromatic ring on N. The system is also active for the synthesis of primary amines. In an attempt to probe the role of MSA and
在[Ru(acac)3 ](acacH = 2,4-戊二酮),三[[1,1,1-三(二苯基膦甲基)乙烷]]和甲磺酸(MSA)的存在下进行酰胺加氢生成仲胺和叔胺如果在N上至少有一个芳环,则其选择性高达93%。该系统对伯胺的合成也具有活性。为了探索MSA的作用和反应机理,已经从[Ru(acac)3 ],三醇和MSA或[RuX(OAc)(triphos)]的反应中制备了一系列甲磺酸钠络合物。 (X = H或OAc)或[RuH 2(CO)(triphos )]与MSA。晶体学表征复合物包括:[茹(OAC-κ 1 O)2(H 2O)(triphos)],[Ru(OAc‐κ 2 O,O')(CH 3 SO 3 ‐κ 1 O)(triphos )],[Ru(CH 3 SO 3‐ κ 1 O)2(H 2 O)(三膦)]和[孺2(μ-CH 3 SO 3)3(三磷酸)2 ] [CH 3 SO 3 ],而其他复合物,例如[茹(OAC-κ